ITPD920071A1 - Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo - Google Patents

Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo

Info

Publication number
ITPD920071A1
ITPD920071A1 IT000071A ITPD920071A ITPD920071A1 IT PD920071 A1 ITPD920071 A1 IT PD920071A1 IT 000071 A IT000071 A IT 000071A IT PD920071 A ITPD920071 A IT PD920071A IT PD920071 A1 ITPD920071 A1 IT PD920071A1
Authority
IT
Italy
Prior art keywords
hyaluronic acid
pct
formation
bone tissue
acid fractions
Prior art date
Application number
IT000071A
Other languages
English (en)
Inventor
Lanfranco Callegaro
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of ITPD920071A0 publication Critical patent/ITPD920071A0/it
Priority to ITPD920071A priority Critical patent/IT1260148B/it
Priority to US08/318,804 priority patent/US5646129A/en
Priority to AU40404/93A priority patent/AU677189B2/en
Priority to AT93911478T priority patent/ATE177641T1/de
Priority to ES93911478T priority patent/ES2130268T3/es
Priority to PCT/EP1993/000932 priority patent/WO1993020827A1/en
Priority to EP93911478A priority patent/EP0637245B1/en
Priority to DE69324006T priority patent/DE69324006T2/de
Priority to CA002118219A priority patent/CA2118219C/en
Priority to JP51799393A priority patent/JP3333205B2/ja
Publication of ITPD920071A1 publication Critical patent/ITPD920071A1/it
Priority to KR1019940703659A priority patent/KR100310277B1/ko
Application granted granted Critical
Publication of IT1260148B publication Critical patent/IT1260148B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
ITPD920071A 1992-04-17 1992-04-17 Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo IT1260148B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITPD920071A IT1260148B (it) 1992-04-17 1992-04-17 Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
EP93911478A EP0637245B1 (en) 1992-04-17 1993-04-16 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
AU40404/93A AU677189B2 (en) 1992-04-17 1993-04-16 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
AT93911478T ATE177641T1 (de) 1992-04-17 1993-04-16 Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung
ES93911478T ES2130268T3 (es) 1992-04-17 1993-04-16 Preparados de acido hialuronico de bajo peso molecular, para estimulacion de formacion de huesos.
PCT/EP1993/000932 WO1993020827A1 (en) 1992-04-17 1993-04-16 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
US08/318,804 US5646129A (en) 1992-04-17 1993-04-16 Method of using low molecular weight hyaluronic acid for stimulating bone formation
DE69324006T DE69324006T2 (de) 1992-04-17 1993-04-16 Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung
CA002118219A CA2118219C (en) 1992-04-17 1993-04-16 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
JP51799393A JP3333205B2 (ja) 1992-04-17 1993-04-16 骨形成を刺激するための低分子量ヒアルロン酸の製法
KR1019940703659A KR100310277B1 (ko) 1992-04-17 1994-10-14 뼈 형성 촉진용 저분자량 하이알루론산의 제조

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD920071A IT1260148B (it) 1992-04-17 1992-04-17 Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo

Publications (3)

Publication Number Publication Date
ITPD920071A0 ITPD920071A0 (it) 1992-04-17
ITPD920071A1 true ITPD920071A1 (it) 1993-10-17
IT1260148B IT1260148B (it) 1996-03-28

Family

ID=11389901

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD920071A IT1260148B (it) 1992-04-17 1992-04-17 Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo

Country Status (11)

Country Link
US (1) US5646129A (it)
EP (1) EP0637245B1 (it)
JP (1) JP3333205B2 (it)
KR (1) KR100310277B1 (it)
AT (1) ATE177641T1 (it)
AU (1) AU677189B2 (it)
CA (1) CA2118219C (it)
DE (1) DE69324006T2 (it)
ES (1) ES2130268T3 (it)
IT (1) IT1260148B (it)
WO (1) WO1993020827A1 (it)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7066794A (en) * 1993-07-01 1995-01-24 Allelix Biopharmaceuticals Inc. Hyaluronic acid fragments and their therapeutic use
IT1282219B1 (it) * 1995-12-20 1998-03-16 Fidia Advanced Biopolymers Srl Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa
US6875753B1 (en) 1996-03-14 2005-04-05 The Governors Of The University Of Alberta Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
US20050101564A1 (en) * 1996-04-02 2005-05-12 Pilarski Linda M. Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
US6872819B1 (en) 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
JP3032824B1 (ja) * 1999-01-28 2000-04-17 東京医科歯科大学長 骨誘導促進剤
DE60020526T2 (de) * 1999-02-04 2006-05-11 SDGI Holdings, Inc., Wilmington Osteogene pastenzusammensetzungen und ihre verwendung
IT1306644B1 (it) 1999-04-08 2001-10-02 Fidia Advanced Biopolymers Srl Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6576226B1 (en) 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
JP2004250592A (ja) * 2003-02-20 2004-09-09 Seikagaku Kogyo Co Ltd 紫外線照射による低分子化グリコサミノグリカンの製造方法
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
US20050226936A1 (en) * 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
US20100075921A1 (en) * 2005-02-15 2010-03-25 Ahmad Alkayali Prêparation of hyaluronic acid with desired low molecular weight as a food supplement
US20060183709A1 (en) * 2005-02-15 2006-08-17 Ahmad Alkayali Preparation of low molecular weight hyaluronic acid as a food supplement
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
EP1994934A4 (en) * 2006-12-05 2010-03-10 Glycoscience Lab Inc THERAPEUTIC AGENT AGAINST DEGENERATIVE ARTHRITIS
US8529951B1 (en) 2007-02-21 2013-09-10 Anand Ramamurthi Elastogenic cues and methods for using same
FR2919185B1 (fr) * 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
CN103255187B (zh) 2012-02-21 2015-02-18 华熙福瑞达生物医药有限公司 一种低分子透明质酸盐、其制备方法及用途
EP3442488A4 (en) * 2016-04-12 2020-03-25 Illustris Pharmaceuticals, Inc. COMPOSITIONS FOR TOPICAL APPLICATION OF COMPOUNDS
JP2018168263A (ja) * 2017-03-29 2018-11-01 日油株式会社 植物性プロテオグリカン及びその用途
US20190105261A1 (en) * 2017-10-11 2019-04-11 Illustris Pharmaceuticals, Inc. Methods and compositions for topical delivery
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3482812D1 (de) * 1983-10-11 1990-08-30 Fidia Spa Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
JP2604135B2 (ja) * 1986-02-28 1997-04-30 ライオン株式会社 口腔骨疾患治療剤
US5041138A (en) * 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
GB2215209B (en) * 1988-03-14 1992-08-26 Osmed Inc Method and apparatus for biodegradable, osteogenic, bone graft substitute device
JPH01265970A (ja) * 1988-04-19 1989-10-24 Shiseido Co Ltd ヒアルロン酸を含有させたコラーゲン水溶液又は水分散液
US5059123A (en) * 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
SE501217C2 (sv) 1990-12-06 1994-12-12 Skandigen Ab Cellproliferationsmatris och användning därav

Also Published As

Publication number Publication date
WO1993020827A1 (en) 1993-10-28
KR100310277B1 (ko) 2001-12-28
JP3333205B2 (ja) 2002-10-15
ATE177641T1 (de) 1999-04-15
EP0637245B1 (en) 1999-03-17
US5646129A (en) 1997-07-08
DE69324006T2 (de) 1999-11-11
AU4040493A (en) 1993-11-18
EP0637245A1 (en) 1995-02-08
DE69324006D1 (de) 1999-04-22
JPH08508973A (ja) 1996-09-24
CA2118219C (en) 2004-06-01
AU677189B2 (en) 1997-04-17
ITPD920071A0 (it) 1992-04-17
IT1260148B (it) 1996-03-28
ES2130268T3 (es) 1999-07-01
CA2118219A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
ITPD920071A1 (it) Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
DE69515183D1 (de) Hypolipidämische benzothiazepine
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
NO307027B1 (no) Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
EA200200806A1 (ru) Предупреждение потери и восстановление костной массы некоторыми агонистами простагландина
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
MX9203050A (es) Compuestos de analogos de triptamina.
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ZA9810735B (en) Novel benzenesulfonamide inhibitors of pde-iv and their therapeutic use
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
ITMI931649A1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
ES2167364T3 (es) Inhibidores de trombina.
DE69221725D1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
YU17999A (sh) Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.
EA199700451A1 (ru) Мономерные 4,4-(дизамещенные) циклогексан-1-олы и родственные соединения
PT907737E (pt) Muteina da il-6
ATE121626T1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
FI20055480A7 (fi) BMP-4-, BMP-12-, BMP-13-ja MP-52-polypeptidien käyttö valmistettaessa sidekudoskiinnityksen regenerointiin tarkoitettuja farmaseuttisia koostumuksia

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990210